Joseph McClellan
Fortuna: 517 568 $ al 31/05/2026
Fortuna: 517 568 $ al 31/05/2026
Joseph E.
McClellan is Chief Scientific Officer at Alvotech hf since 2019.
Dr. McClellan is Chief Operating Officer at Alvotech starting in 2025.
Formerly, Dr. McClellan was Global Head-Biosimilars Development & Medicine at Pfizer Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from the University of Florida, and an MBA from Northeastern University (China).
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALVOTECH 0,05 % | 06/03/2026 | 154.038 ( 0,05 % ) | 517 568 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALVOTECH | Director de Operaciones | 12/11/2025 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Director Técnico/Científico/I+D | 01/10/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University (China)
Northeastern University (China) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.